People's United Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $9.15M | Sell |
31,963
-11,720
| -27% | -$3.02M | 0.26% | 101 |
|
|
2021
Q4 | $12.1M | Sell |
43,683
-12,889
| -23% | -$3.27M | 0.29% | 91 |
|
|
2021
Q3 | $13.1M | Buy |
56,572
+5,089
| +10% | +$1.26M | 0.29% | 90 |
|
|
2021
Q2 | $11.8M | Sell |
51,483
-3,004
| -6% | -$603K | 0.26% | 93 |
|
|
2021
Q1 | $10.2M | Sell |
54,487
-1,041
| -2% | -$204K | 0.24% | 98 |
|
|
2020
Q4 | $9.38M | Sell |
55,528
-474
| -0.8% | -$70.8K | 0.23% | 100 |
|
|
2020
Q3 | $8.29M | Sell |
56,002
-6,717
| -11% | -$1.04M | 0.23% | 99 |
|
|
2020
Q2 | $10.3M | Sell |
62,719
-1,154
| -2% | -$177K | 0.3% | 89 |
|
|
2020
Q1 | $8.86M | Sell |
63,873
-8,592
| -12% | -$1.18M | 0.31% | 86 |
|
|
2019
Q4 | $9.52M | Sell |
72,465
-2,962
| -4% | -$343K | 0.26% | 95 |
|
|
2019
Q3 | $8.44M | Sell |
75,427
-9,230
| -11% | -$1.03M | 0.24% | 94 |
|
|
2019
Q2 | $9.38M | Buy |
84,657
+2,995
| +4% | +$353K | 0.26% | 89 |
|
|
2019
Q1 | $10.6M | Sell |
81,662
-919
| -1% | -$112K | 0.33% | 75 |
|
|
2018
Q4 | $9.56M | Buy |
82,581
+8,515
| +11% | +$951K | 0.33% | 73 |
|
|
2018
Q3 | $7.95M | Sell |
74,066
-1,512
| -2% | -$151K | 0.25% | 90 |
|
|
2018
Q2 | $6.45M | Sell |
75,578
-14,200
| -16% | -$1.17M | 0.17% | 160 |
|
|
2018
Q1 | $6.95M | Sell |
89,778
-10,679
| -11% | -$860K | 0.22% | 103 |
|
|
2017
Q4 | $8.48M | Sell |
100,457
-16,782
| -14% | -$1.43M | 0.26% | 89 |
|
|
2017
Q3 | $10M | Buy |
117,239
+3,639
| +3% | +$298K | 0.34% | 78 |
|
|
2017
Q2 | $9.35M | Sell |
113,600
-1,358
| -1% | -$111K | 0.32% | 75 |
|
|
2017
Q1 | $9.67M | Sell |
114,958
-1,131
| -1% | -$90.6K | 0.34% | 74 |
|
|
2016
Q4 | $8.54M | Buy |
116,089
+10,405
| +10% | +$775K | 0.32% | 84 |
|
|
2016
Q3 | $8.48M | Buy |
105,684
+2,113
| +2% | +$169K | 0.45% | 65 |
|
|
2016
Q2 | $8.16M | Buy |
103,571
+2,523
| +2% | +$190K | 0.44% | 66 |
|
|
2016
Q1 | $7.28M | Buy |
101,048
+2,136
| +2% | +$162K | 0.39% | 72 |
|
|
2015
Q4 | $8.33M | Buy |
98,912
+4,368
| +5% | +$362K | 0.44% | 66 |
|
|
2015
Q3 | $7.91M | Sell |
94,544
-10,036
| -10% | -$847K | 0.45% | 60 |
|
|
2015
Q2 | $8.73M | Sell |
104,580
-2,999
| -3% | -$229K | 0.46% | 62 |
|
|
2015
Q1 | $7.82M | Buy |
107,579
+1,110
| +1% | +$79K | 0.4% | 68 |
|
|
2014
Q4 | $7.34M | Buy |
106,469
+7,391
| +7% | +$499K | 0.37% | 72 |
|
|
2014
Q3 | $6.43M | Buy |
99,078
+14,863
| +18% | +$941K | 0.34% | 73 |
|
|
2014
Q2 | $5.24M | Buy |
84,215
+6,996
| +9% | +$417K | 0.28% | 86 |
|
|
2014
Q1 | $4.54M | Buy |
77,219
+7,094
| +10% | +$396K | 0.27% | 89 |
|
|
2013
Q4 | $3.58M | Buy |
70,125
+4,079
| +6% | +$204K | 0.21% | 97 |
|
|
2013
Q3 | $3.32M | Buy |
66,046
+5,009
| +8% | +$262K | 0.21% | 88 |
|
|
2013
Q2 | $3M | Buy |
+61,037
| New | +$3.32M | 0.19% | 90 |
|
Other funds holding LLY
People's United Financial's LLY Position: Q1 2022 in Review
People's United Financial reduced its Eli Lilly (LLY) stake by 27% in Q1 2022, selling an estimated $3.02M and leaving 31,963 shares worth $9.15M. The position accounts for 0.26% of the portfolio, ranked #101.
People's United Financial first reported a position in LLY in Q2 2013 and has held it in 36 quarters since. The position peaked at $13.1M in Q3 2021. 2,346 funds tracked by Wall St. Rank hold LLY as of Q1 2022.
- People's United Financial held 31,963 shares of Eli Lilly worth $9.15M as of Q1 2022.
- People's United Financial sold 11,720 Eli Lilly shares in Q1 2022, an estimated $3.02M.
- Eli Lilly made up 0.26% of People's United Financial's portfolio in Q1 2022, its #101 holding.
- People's United Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 36 quarters since.
- People's United Financial's Eli Lilly position peaked at $13.1M in Q3 2021.
- 2,346 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.
Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.